These final results, together with a former report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the thought of focusing on ACKR3 as a novel method to modulate the opioid technique, which could open new therapeutic avenues for opioid-connected disorders.Importantly, these receptors wer